Coping and Attachment in Pediatric Oncohematology (CopAt)

April 23, 2026 updated by: Marco Zecca, Fondazione IRCCS Policlinico San Matteo di Pavia

Coping and Attachment in Pediatric Oncohematology: Multicenter Cross-sectional Study to Assess Emotional Resources and Attachment Dynamics Related to Coping Strategies in Parents of Children With Oncohematologic Disease

Cancer can be a traumatic and particularly salient experience in a person's history. The ways in which the pediatric patient copes with it depend on the interaction of several factors present in his or her life context, primarily the relationship that is established between parent and child.

Despite the paucity of studies in the literature in this regard, it would seem that parental coping is predictive of child coping. Coping strategies represent the ways in which people try to manage traumatic events or stressful everyday situations.

Currently, the literature identifies two main categories of coping strategies: emotion-oriented and problem-oriented strategies. The former are aimed on reducing stress-induced unpleasant emotions (e.g., problem avoidance, positive reappraisal, etc.); the latter, on the other hand, focus on stress dissolution/alteration (e.g., problem identification and resolution, stress cause research). Some studies, previously conducted in oncology, show that emotion-focused coping strategies are associated with better adaptation immediately after diagnosis, but their positive influence tends to weaken over time; problem-focused coping strategies are more correlated with poor adaptation immediately after diagnosis, but in the later stages of treatment.

The clinical experience with patients in the Pediatric Oncohematology Department brings out the need to develop and structure a psychological assessment model, in order to ensure a more effective care of the family units followed.

The research aims, through a single administration of psychological tests, to investigate the role of attachment and some variables (age, gender, stage of treatment, stage of the disease, social support, resilience, ability to adapt to environmental stimuli, emotional state of of caregivers) on the coping strategies implemented by the parents of patients and the patients themselves, in order to differentiate the types of psychological intervention, to try to reduce psychological distress and increase levels of mental well-being.

Study Overview

Study Type

Observational

Enrollment (Estimated)

60

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Monza-Brianza
      • Monza, Monza-Brianza, Italy, 20900
        • Recruiting
        • Ospedale San Gerardo, SC Ematologia Pediatrica
    • Pavia
      • Pavia, Pavia, Italy, 27100
        • Recruiting
        • SC Ematologia 2 - Oncoematologia pediatrica
        • Contact:
    • Taranto
      • Taranto, Taranto, Italy, 74100
        • Recruiting
        • Struttura Complessa di Pediatria e Oncoematologia Pediatrica, Ospedale SS Annunziata
        • Contact:
          • Maria Montanaro

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Parents (single/father and mother) of patients in care of Pediatric Oncohematology departments who meet the inclusion criteria and pediatric patients in treatment at the Pediatric Oncohematology departments who meet the inclusion criteria.

Description

Parents Inclusion Criteria:

  • parents of both sexes
  • age of son/daughter between 8 and 17 years old (included)
  • son/daughter being treated at the Pediatric Oncohematology departments involved in the research (Day Hospital and hospitalization)
  • good understanding of the Italian language

Parents Exclusion Criteria:

● son/daughter in off-therapy

Patients Inclusion Criteria:

  • age between 8 and 17 years old (included), undergoing treatment at the Pediatric Oncohematology departments (Day Hospital and hospitalization)
  • parents enrolled in the study
  • good understanding of the Italian language

Patients Exclusion Criteria:

● patients in off-therapy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Parents cohort

Father and mother of each patient in care at the Pediatric Oncohematology department and enrolled in the study.

The correlation between attachment dynamics and emotional care resources related to coping strategies will be assessed.

Administration of psychological tests will take place one time after the enrollment in the study.

Patients cohort
Pediatric patients in care at the Pediatric Oncohematology department. Administration of psychological tests will take place one time after the enrollment in the study.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Child-Parent Relationship Scale
Time Frame: One time just after the enrollment
Child-Parent Relationship Scale is a 30-item, self-report instrument used to assess conflict and relational closeness, two important aspects in the emotional support provided to the child and compliance with care, as well as perceived parental distress. The Likert scale ranges from 1 to 5, where 1 stands for "Absolutely not true" and 5 stands for "Definitely true." Scoring is done by summing the raw scores of the items in the three sections (positive aspects of the relationship, conflict and dependence) divided by the items in each sub-scale (mean score).
One time just after the enrollment
Coping Orientations to Problem Experienced
Time Frame: One time just after the enrollment
"Coping Orientations to Problem Experienced- New Italian Version" is a self-report questionnaire that considers different coping modes. The Likert scale ranges from 1 to 4, where 1 stands for "I usually don't do it" and 4 stands for "I almost always do it." The instrument consists of 60 items, divided into 5 independent dimensions: social support, avoidance strategies, positive attitude, problem orientation and transcendent orientation. The scores from 1 to 4 are based on the responses identified by the subject for each item except for 4 "reverse" responses (items 8-20-36-50) for which the chosen score must be reversed. The items are then divided into groups for the identification of the 5 coping factors (social support, avoidance, positive attitude and transcendent orientation). Higher scores indicate greater use of that specific coping strategy.
One time just after the enrollment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 12, 2023

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Study Registration Dates

First Submitted

February 27, 2025

First Submitted That Met QC Criteria

February 27, 2025

First Posted (Actual)

March 5, 2025

Study Record Updates

Last Update Posted (Actual)

April 24, 2026

Last Update Submitted That Met QC Criteria

April 23, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CopAt

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe